Home Search
cancer - search results
If you're not happy with the results, please do another search
Advocating for equity in childhood cancer care
A scarcity of suitable therapies and geographic disparities in access to care are impacting survival rates for children with cancer; Lorna Rothery spoke to the European branch of Childhood Cancer International, a pan-European organisation committed to improving outcomes for children and adolescents affected by cancer.
Microwave ablation emerges as a promising treatment for thyroid cancer
Researchers suggest that microwave ablation, a minimally invasive procedure, could offer comparable progression-free survival rates to surgery with fewer complications.
Investigating lung cancer using genetically engineered mouse models (GEMMS)
Daniel J. Murphy, Professor of Lung Cancer & Mesothelioma at the University of Glasgow, School of Cancer Sciences, discusses opportunities for improving cancer research and care through the use of genetically engineered mouse models.
Are nanotextures enough to kill cancer cells?
Nanotextures on nanoparticles and implants to kill cancer cells in a more targeted manner may just be the key to tackling resistance to traditional cancer drugs.
Breakthrough prostate cancer treatment shows less side affects and better outcomes
A minimally invasive treatment for prostate cancer, using a combination of MRI and transurethral ultrasound, has shown effectiveness in a recent study.
Delivering the best policy for cancer patients: Follow the science – follow the data
Mark Lawler, from the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast, reflects on key milestones in cancer policy initiatives and how data support innovative cancer research, optimal care and equity of access.
Endocrine disrupting chemicals: the role they play in breast cancer
Dr Alice Di Pasquale, Scientific Research Officer at Breast Cancer UK, explains why more must be done to increase awareness of Endocrine Disrupting Chemicals and breast cancer risk.
Development of novel therapies for pediatric cancer: Successes and challenges
Peter J. Houghton from Greehey Children’s Cancer Research Institute and Mary-Ann Bjornsti from the University of Alabama discuss some of the key challenges in the development of therapies for pediatric cancer care.
Scientists record a decline in cancer related deaths among rising cancer cases
New research looks at cancer cases in the UK, revealing complex factors driving progress and challenges.
Drug development could help treat one of the most challenging cancers
A new drug development could help those battling pancreatic cancer, one of the most challenging cancers to treat.
Engineered endosymbionts as novel cancer therapeutics
Satyajit Hari Kulkarni and Christopher H. Contag from the Institute for Quantitative Health Science and Engineering focus on engineered endosymbionts, which they argue is a paradigm shift in anticancer bacteriotherapy toward killing tumors from the inside out.
Predicting improved response to lung cancer immunotherapy
Researchers have identified 140 genes that could change how non-small cell lung cancer (NSCLC) patients are treated with immunotherapy and low-dose radiation.
World Cancer Day: Digital cancer care to address UK inequity
Paul Landau, CEO of Careology, a digital cancer care platform used by the NHS and private health sector, posits the need for smart investment into digital tools to support cancer care and maximise the efficiency of resources.
AI cancer treatment: AI tool to enhance precision for cancer treatment
A new cutting-edge artificial intelligence tool has been developed to revolutionise cancer treatment.
People-centred health services are essential to reducing disparities in cancer care
The past ten years have seen significant progress in cancer care, detecting cancers earlier and managing them more successfully and less invasively on a global scale.
Skin cancer mutation offers hope for healing broken hearts
Is there a way to mend a broken heart? Biomedical engineers have found a potential way to mend a broken heart using a genetic mutation commonly associated with skin cancers.
The non-invasive cancer-grade probing system
Researchers have introduced a non-invasive method for determining the malignancy grade of glioma tumours.
AI unlocks cancer treatment secrets
Using artificial intelligence, scientists have tackled one of the toughest challenges in cancer research.
Researchers reveal blood cell traits influence risk of rare blood cancer
Scientists have revealed how common variations in our blood cells can act as unexpected allies to cancer-causing mutations.